These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8891146)

  • 1. Potent activity of 2'-beta-fluoro-2',3'-dideoxyadenosine against human immunodeficiency virus type 1 infection in hu-PBL-SCID mice.
    Ruxrungtham K; Boone E; Ford H; Driscoll JS; Davey RT; Lane HC
    Antimicrob Agents Chemother; 1996 Oct; 40(10):2369-74. PubMed ID: 8891146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The human HIV/peripheral blood lymphocyte (PBL)-SCID mouse. A modified human PBL-SCID model for the study of HIV pathogenesis and therapy.
    Boyle MJ; Connors M; Flanigan ME; Geiger SP; Ford H; Baseler M; Adelsberger J; Davey RT; Lane HC
    J Immunol; 1995 Jun; 154(12):6612-23. PubMed ID: 7759895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-performance liquid chromatographic analysis of 2'-fluoro-2',3'-dideoxyadenosine and 2'-fluoro-2',3'-dideoxyinosine in dog plasma and urine.
    Campbell DA; Shah VR; Srinivas NR; Shyu WC
    J Pharm Sci; 1996 Aug; 85(8):890-2. PubMed ID: 8863284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single dose and multiple dose pharmacokinetics of 2'-fluoro-2',3'-dideoxyadenosine and 2'-fluoro-2',3'-dideoxyinosine, anti-HIV agents, in rats.
    Srinivas NR; Shyu WC
    Eur J Drug Metab Pharmacokinet; 1999; 24(4):329-34. PubMed ID: 10892896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human immunodeficiency virus type 1 strains R5 and X4 induce different pathogenic effects in hu-PBL-SCID mice, depending on the state of activation/differentiation of human target cells at the time of primary infection.
    Fais S; Lapenta C; Santini SM; Spada M; Parlato S; Logozzi M; Rizza P; Belardelli F
    J Virol; 1999 Aug; 73(8):6453-9. PubMed ID: 10400739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell dysfunctions in hu-PBL-SCID mice infected with human immunodeficiency virus (HIV) shortly after reconstitution: in vivo effects of HIV on highly activated human immune cells.
    Rizza P; Santini SM; Logozzi MA; Lapenta C; Sestili P; Gherardi G; Lande R; Spada M; Parlato S; Belardelli F; Fais S
    J Virol; 1996 Nov; 70(11):7958-64. PubMed ID: 8892919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pertussis toxin B-oligomer inhibits HIV infection and replication in hu-PBL-SCID mice.
    Lapenta C; Spada M; Santini SM; Racca S; Dorigatti F; Poli G; Belardelli F; Alfano M
    Int Immunol; 2005 Apr; 17(4):469-75. PubMed ID: 15746245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type I interferon is a powerful inhibitor of in vivo HIV-1 infection and preserves human CD4(+) T cells from virus-induced depletion in SCID mice transplanted with human cells.
    Lapenta C; Santini SM; Proietti E; Rizza P; Logozzi M; Spada M; Parlato S; Fais S; Pitha PM; Belardelli F
    Virology; 1999 Oct; 263(1):78-88. PubMed ID: 10544084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection of hu-PBL-SCID/beige mice from HIV-1 infection by a 6-mer modified oligonucleotide, R-95288.
    Agatsuma T; Abe K; Furukawa H; Koga R; Koizumi M; Hotoda H; Kaneko M
    Antiviral Res; 1997 May; 34(3):121-30. PubMed ID: 9191019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo toxicity, pharmacokinetics, and anti-human immunodeficiency virus activity of stavudine-5'-(p-bromophenyl methoxyalaninyl phosphate) (stampidine) in mice.
    Uckun FM; Qazi S; Pendergrass S; Lisowski E; Waurzyniak B; Chen CL; Venkatachalam TK
    Antimicrob Agents Chemother; 2002 Nov; 46(11):3428-36. PubMed ID: 12384347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of human immunodeficiency virus (HIV-1) infection in human peripheral blood leucocytes-SCID reconstituted mice by rapamycin.
    Nicoletti F; Lapenta C; Donati S; Spada M; Ranazzi A; Cacopardo B; Mangano K; Belardelli F; Perno C; Aquaro S
    Clin Exp Immunol; 2009 Jan; 155(1):28-34. PubMed ID: 19076826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FddA: antiretroviral in development.
    Hanna L
    BETA; 1998 Oct; ():7-8. PubMed ID: 11365997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Saquinavir-mediated inhibition of human immunodeficiency virus (HIV) infection in SCID mice implanted with human fetal thymus and liver tissue: an in vivo model for evaluating the effect of drug therapy on HIV infection in lymphoid tissues.
    Pettoello-Mantovani M; Kollmann TR; Raker C; Kim A; Yurasov S; Tudor R; Wiltshire H; Goldstein H
    Antimicrob Agents Chemother; 1997 Sep; 41(9):1880-7. PubMed ID: 9303378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance to human immunodeficiency virus 1 infection of SCID mice reconstituted with peripheral blood leukocytes from donors vaccinated with vaccinia gp160 and recombinant gp160.
    Mosier DE; Gulizia RJ; MacIsaac PD; Corey L; Greenberg PD
    Proc Natl Acad Sci U S A; 1993 Mar; 90(6):2443-7. PubMed ID: 8460155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro induction of human immunodeficiency virus type 1 variants resistant to 2'-beta-Fluoro-2',3'-dideoxyadenosine.
    Tanaka M; Srinivas RV; Ueno T; Kavlick MF; Hui FK; Fridland A; Driscoll JS; Mitsuya H
    Antimicrob Agents Chemother; 1997 Jun; 41(6):1313-8. PubMed ID: 9174190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human immunodeficiency virus type 1 infection of neonatal severe combined immunodeficient mice xenografted with human cord blood cells.
    Reinhardt B; Torbett BE; Gulizia RJ; Reinhardt PP; Spector SA; Mosier DE
    AIDS Res Hum Retroviruses; 1994 Feb; 10(2):131-41. PubMed ID: 8198867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfer of human CD4(+) T lymphocytes producing beta interferon in Hu-PBL-SCID mice controls human immunodeficiency virus infection.
    Vieillard V; Jouveshomme S; Leflour N; Jean-Pierre E; Debre P; De Maeyer E; Autran B
    J Virol; 1999 Dec; 73(12):10281-8. PubMed ID: 10559345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral administration of the nucleoside EFdA (4'-ethynyl-2-fluoro-2'-deoxyadenosine) provides rapid suppression of HIV viremia in humanized mice and favorable pharmacokinetic properties in mice and the rhesus macaque.
    Stoddart CA; Galkina SA; Joshi P; Kosikova G; Moreno ME; Rivera JM; Sloan B; Reeve AB; Sarafianos SG; Murphey-Corb M; Parniak MA
    Antimicrob Agents Chemother; 2015 Jul; 59(7):4190-8. PubMed ID: 25941222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MDL 74,968, a new acyclonucleotide analog: activity against human immunodeficiency virus in vitro and in the hu-PBL-SCID.beige mouse model of infection.
    Bridges CG; Taylor DL; Ahmed PS; Brennan TM; Hornsperger JM; Navé JF; Casara P; Tyms AS
    Antimicrob Agents Chemother; 1996 May; 40(5):1072-7. PubMed ID: 8723443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaginal transmission of HIV-1 in hu-SCID mice: a new model for the evaluation of vaginal microbicides.
    Di Fabio S; Giannini G; Lapenta C; Spada M; Binelli A; Germinario E; Sestili P; Belardelli F; Proietti E; Vella S
    AIDS; 2001 Nov; 15(17):2231-8. PubMed ID: 11698695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.